XM does not provide services to residents of the United States of America.

China targets European firms in anti-subsidy probe into EU dairy



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-China targets European firms in anti-subsidy probe into EU dairy</title></head><body>

Adds details, background from paragraph 4

By Mei Mei Chu

BEIJING, Oct 14 (Reuters) -China on Monday singled out Dutch firm FrieslandCampina as well as French and Italian companies in an anti-subsidy probe into dairy imports from the European Union, after lawmakers from these countries voted for tariffs on Chinese electric vehicles.

The world's second-largest economy launched the investigation into imports of some cheese, milk and cream from the European Union in August.

Details of the probe come after EU members on Oct. 4 voted in favour of imposing tariffs of up to 45% on imported Chinese EVs.

Italy, France, and the Netherlands had voted in favour of the tariffs, while Belgium had abstained.

China's commerce ministry said it would use samples collected from Elvi (France) Co., Ltd. (ELVIR), FrieslandCampina Nederland B.V., FrieslandCampina Belgium N.V. as well as Italian firm Sterilgarda Alimenti SPA in its investigation.

The companies were selected based on export volume, product structure and geographical distribution, the ministry said in a statement.

The European Commission has launched a challenge at the World Trade Organisation (WTO) against China's probe, the first time it has taken such action at the start of an investigation, rather than wait for it to result in trade measures against the bloc.

The EU was China's second-largest source of dairy products, behind only New Zealand, according to Chinese customs data.

The bloc exported 1.7 billion euros ($1.84 billion) in dairy products to China in 2023, according to data from the European Commission's Directorate-General for Agriculture and Rural Development, which cited Eurostat.



Reporting by Mei Mei Chu
Editing by Bernadette Baum and Sharon Singleton

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.